Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event …

F Khan, A Rahman, M Carrier, C Kearon, JI Weitz… - bmj, 2019 - bmj.com
Objectives To determine the rate of a first recurrent venous thromboembolism (VTE) event
after discontinuation of anticoagulant treatment in patients with a first episode of unprovoked …
被引用次数：275 相关文章
[HTML] bmj.com

[HTML][HTML] Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous …

F Khan, A Rahman, M Carrier, C Kearon, JI Weitz… - BMJ, 2019 - bmj.com
Objectives To determine the rate of a first recurrent venous thromboembolism (VTE) event
after discontinuation of anticoagulant treatment in patients with a first episode of unprovoked …
[PDF] archive.org

[PDF][PDF] Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism …

F Khan, A Rahman, M Carrier, C Kearon, JI Weitz… - bmj, 2019 - scholar.archive.org
ABSTRACT OBJECTIVES To determine the rate of a first recurrent venous
thromboembolism (VTE) event after discontinuation of anticoagulant treatment in patients …
[PDF] researchgate.net

[PDF][PDF] Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism …

F Khan, A Rahman, M Carrier, C Kearon, JI Weitz… - bmj, 2019 - researchgate.net
ABSTRACT OBJECTIVES To determine the rate of a first recurrent venous
thromboembolism (VTE) event after discontinuation of anticoagulant treatment in patients …

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event …

F Khan, A Rahman, M Carrier… - BMJ (Clinical …, 2019 - researchinformation.amsterdamumc …
To determine the rate of a first recurrent venous thromboembolism (VTE) event after
discontinuation of anticoagulant treatment in patients with a first episode of unprovoked VTE …

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event …

F Khan, A Rahman, M Carrier, C Kearon… - BMJ (e …, 2019 - cris.maastrichtuniversity.nl
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of
anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review …

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event …

F Khan, A Rahman, M Carrier, C Kearon, JI Weitz… - BMJ, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objectives</jats: title>< jats: p>
To determine the rate of a first recurrent venous thromboembolism (VTE) event after …

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event …

F Khan, A Rahman, M Carrier, C Kearon… - … (Clinical Research ed …, 2019 - europepmc.org
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of
anticoagulant treatment for first unprovoked venous thromboembolism event: systematic …
[HTML] nih.gov

[HTML][HTML] Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous …

F Khan, A Rahman, M Carrier, C Kearon, JI Weitz… - The BMJ, 2019 - ncbi.nlm.nih.gov
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of
anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review …

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event …

F Khan, A Rahman, M Carrier… - BMJ (Clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Objectives To determine the rate of a first recurrent venous thromboembolism (VTE) event
after discontinuation of anticoagulant treatment in patients with a first episode of unprovoked …